焦磷酸钙沉积症

McCarty DJ. Diagnostic mimicry in arthritis: patterns of joint involvement associated with calcium pyrophosphate dihydrate crystal deposits. Bull Rheum Dis. 1975;25:804-809.

Rosenthal A, Ryan LM. Calcium pyrophosphate crystal deposition diseases, pseudogout, and articular chondrocalcinosis. In: Koopman WJ, Moreland LW, eds. Arthritis and allied conditions. 15th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:2373-2396.

Martinez Sanchis A, Pascual E. Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy. Ann Rheum Dis. 2005 Dec;64(12):1769-72.

• 摘要

Frediani B, Filippou G, Falsetti P, et al. Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. Ann Rheum Dis. 2005 Apr;64(4):638-40.

• 全文
• 摘要

Zhang W, Doherty M, Pascual E, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011 Apr;70(4):571-5.

• 全文
• 摘要

O'Duffy JD. Clinical studies of acute pseudogout attacks: comments on prevalence, predispositions, and treatment. Arthritis Rheum. 1976 May-Jun;19(suppl 3):349-52.

• 摘要

Creamer P. Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol. 1999 Sep;11(5):417-21.

• 摘要

1.  McCarty DJ. Diagnostic mimicry in arthritis: patterns of joint involvement associated with calcium pyrophosphate dihydrate crystal deposits. Bull Rheum Dis. 1975;25:804-809.

2.  Zhang W, Doherty M, Bardin T, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011 Apr;70(4):563-70.

• 全文
• 摘要

3.  Abhishek A, Doherty S, Maciewicz R, et al. Association between low cortical bone mineral density, soft-tissue calcification, vascular calcification and chondrocalcinosis: a case-control study. Ann Rheum Dis. 2014 Nov;73(11):1997-2002.

• 摘要

4.  Fisseler-Eckhoff A, Muller KM. Arthroscopy and chondrocalcinosis. Arthroscopy. 1992;8(1):98-104.

• 摘要

5.  Wilkins E, Dieppe P, Maddison P, et al. Osteoarthritis and articular chondrocalcinosis in the elderly. Ann Rheum Dis. 1983 Jun;42(3):280-4.

• 全文
• 摘要

6.  Neame R, Carr A, Muir K, et al. UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis. 2003 Jun;62(6):513-8.

• 全文
• 摘要

7.  Al-Arfaj AS, Boukai AA. Articular chondrocalcinosis in Saudi Arabia. Saudi Med J. 2002 May;23(5):577-9.

• 摘要

8.  Malaviya AN, Al-Shari I, Al-Shayeb A, et al. Calcium pyrophosphate dihydrate (CPPD) crytal deposition disease in a teaching hospital in Kuwait. Ann Rheum Dis. 2001 Apr;60(4):416-9.

• 全文
• 摘要

9.  Zhang Y, Terkeltaub R, Nevitt M, et al. Lower prevalence of chondrocalcinosis in Chinese subjects in Beijing than in white subjects in the United States: the Beijing Osteoarthritis Study. Arthritis Rheum. 2006 Nov;54(11):3508-12.

• 摘要

10.  Rosenthal A, Ryan LM. Calcium pyrophosphate crystal deposition diseases, pseudogout, and articular chondrocalcinosis. In: Koopman WJ, Moreland LW, eds. Arthritis and allied conditions. 15th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:2373-2396.

11.  Ryan LM, Cheung HS, McCarty DJ. Release of pyrophosphate by normal mammalian articular hyaline and fibrocartilage in organ culture. Arthritis Rheum. 1981 Dec;24(12):1522-7.

• 摘要

12.  Bjelle A. Cartilage matrix in hereditary pyrophosphate arthropathy. J Rheumatol. 1981 Nov-Dec;8(6):959-64.

• 摘要

13.  Ryan LM, Kurup I, Rosenthal AK, et al. Stimulation of inorganic pyrophosphate elaboration by cultured cartilage and chondrocytes. Arch Biochem Biophys. 1989 Aug 1;272(2):393-9.

• 摘要

14.  Rosenthal AK, Cheung HS, Ryan LM. Transforming growth factor beta 1 stimulates inorganic pyrophosphate elaboration by porcine cartilage. Arthritis Rheum. 1991 Jul;34(7):904-11.

• 摘要

15.  Landis RC, Haskard DO. Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep. 2001 Feb;3(1):36-41.

• 摘要

16.  Martinez Sanchis A, Pascual E. Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy. Ann Rheum Dis. 2005 Dec;64(12):1769-72.

• 摘要

17.  Cheung HS. Calcium crystal effects on the cells of the joint: implications for the pathogenesis of disease. Curr Opin Rheumatol. 2000 May;12(3):223-7.

• 摘要

18.  Mitrovic DR, Stankovic A, Iriarte-Borda O, et al. The prevalence of chondrocalcinosis in the human knee joint. An autopsy survey. J Rheumatol. 1988 Apr;15(4):633-41.

• 摘要

19.  Doherty M, Watt I, Dieppe PA. Localised chondrocalcinosis in post-meniscectomy knees. Lancet. 1982 May 29;1(8283):1207-10.

• 摘要

20.  Rynes RI, Merzig EG. Calcium pyrophosphate crystal deposition disease and hyperparathryoidism: a controlled, prospective study. J Rheumatol. 1978 Winter;5(4):460-8.

• 摘要

21.  Van Geertruyden J, Kinneart P, Frederick N, et al. Effect of parathyroid surgery on cartilage calcification. World J Surg. 1986 Feb;10(1):111-5.

• 摘要

22.  Dymock IW, Hamilton EB, Laws JW, et al. Arthropathy of haemochromatosis: clinical and radiological analysis of 63 patients with iron overload. Ann Rheum Dis. 1970 Sep;29(5):469-76.

• 全文
• 摘要

23.  Dorfmann H, Solnica J, Di Menza C, et al. The arthropathies of hemochromatosis. Results of a prospective study of 54 patients [in French]. Sem Hop. 1969 Feb 14;45(8):516-23.

• 摘要

24.  Pawlotsky Y, Le Dantec P, Moirand R, et al. Elevated parathryoid hormone 44-68 and osteoarticular changes in patients with genetic hemochromatosis. Arthritis Rheum. 1999 Apr;42(4):799-806.

• 摘要

25.  Hearn PR, Russell RG, Elliott JC. Formation product of calcium pyrophosphate crystals in vitro and the effect of iron salts. Clin Sci Mol Med. 1978 Feb 1;54(2):29.

26.  Couto AR, Brown MA. Genetic factors in the pathogenesis of CPPD crystal deposition disease. Curr Rheumatol Rep. 2007 Jun;9(3):231-6.

• 摘要

27.  Williams CJ. Familial calcium pyrophosphate dihydrate deposition disease and the ANKH gene. Curr Opin Rheumatol. 2003 May;15(3):326-31.

• 摘要

28.  Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in tissue calcification and arthritis. Science. 2000 Jul 14;289(5477):265-70.

• 摘要

29.  Ramos YF, Bos SD, van der Breggen R, et al. A gain of function mutation in TNFRSF11B encoding osteoprotegerin causes osteoarthritis with chondrocalcinosis. Ann Rheum Dis. 2015 Sep;74(9):1756-62.

• 摘要

30.  Punzi L, Calo L, Schiavon F, et al. Chondrocalcinosis is a feature of Gitelman's variant of Bartter's syndrome: a new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition diseae. Rev Rheum Engl Ed. 1998 Oct;65(10):571-4.

• 摘要

31.  Richette P, Ayoub G, Bardin T, et al. Hypomagnesemia and chondrocalcinosis in short bowel syndrome. J Rheumatol. 2005 Dec;32(12):2434-6.

• 摘要

32.  Whyte M. Hypophosphatasia. In: Scriver CR, Beaudet AR, Sly WS, et al, eds. The metabolic basis of inherited disease. 6th ed. New York, NY: McGraw-Hill; 1989:22843-22856.

33.  Chuck AJ, Pattrick MG, Hamilton E, et al. Crystal deposition in hypophosphatasia: a reappraisal. Ann Rheum Dis. 1989 Jul;48(7):571-6.

• 全文
• 摘要

34.  Jaccard YB, Gerster JC, Calame L. Mixed monosodium urate and calcium pyrophosphate crystal-induced arthropathy: a review of seventeen cases. Rev Rheum Engl Ed. 1996 May;63(5):331-5.

• 摘要

35.  Hollingworth P, Williams PL, Scott JT. Frequency of chondrocalcinosis of the knees in asymptomatic hyperuricemia and rheumatoid arthritis: a controlled study. Ann Rheum Dis. 1982 Aug;41(4):344-6.

• 全文
• 摘要

36.  Jones AC, Chuck AJ, Arie EA, et al. Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum. 1992 Dec;22(3):188-202.

• 摘要

37.  Chaisson CE, McAlindon TE, Felson DT, et al. Lack of association between thyroid status and chondrocalcinosis or osteoarthritis: the Framingham Osteoarthritis Study. J Rheumatol. 1996 Apr;23(4):711-5.

• 摘要

38.  Ryan L, McCarty DJ. Calcium pyrophosphate crystal deposition disease; pseudogout; articular chondrocalcinosis. In: McCarty DJ, ed. Arthritis and allied conditions. 11th ed. Philadelphia, PA: Lea & Febiger; 1989:1711-1736.

39.  Frediani B, Filippou G, Falsetti P, et al. Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. Ann Rheum Dis. 2005 Apr;64(4):638-40.

• 全文
• 摘要

40.  Suan JC, Chhem RK, Gati JS, et al. 4 T MRI of chondrocalcinosis in combination with three-dimensional CT, radiography, and arthroscopy: a report of three cases. Skeletal Radiol. 2005 Nov;34(11):714-21.

• 摘要

41.  Löffler C, Sattler H, Peters L, et al. Distinguishing gouty arthritis from calcium pyrophosphate disease and other arthritides. J Rheumatol. 2015 Mar;42(3):513-20.

• 摘要

42.  Masuda I, Ishikawa K. Clinical features of pseudogout attack: a survey of 50 cases. Clin Orthop Relat Res. 1988 Apr;(229):173-81.

• 摘要

43.  Halverson PB, Carrera GF, McCarty DJ. Milwaukee shoulder syndrome: fifteen additional cases and a description of contributing factors. Arch Intern Med. 1990 Mar;150(3):677-82.

• 摘要

44.  Zhang W, Doherty M, Pascual E, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011 Apr;70(4):571-5.

• 全文
• 摘要

45.  O'Duffy JD. Clinical studies of acute pseudogout attacks: comments on prevalence, predispositions, and treatment. Arthritis Rheum. 1976 May-Jun;19(suppl 3):349-52.

• 摘要

46.  Creamer P. Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol. 1999 Sep;11(5):417-21.

• 摘要

47.  Meed SD, Spilberg I. Successful use of colchicine in acute polyarticular pseudogout. J Rheumatol. 1981 Jul-Aug;8(4):689-91.

• 摘要

48.  Neuss MN, McCallum RM, Brenckman WD, et al. Long-term colchicine administration leading to colchicine toxicity and death. Arthritis Rheum. 1986 Mar;29(3):448-9.

• 摘要

49.  Roane DW, Harris MD, Carpenter MT, et al. Prospective use of intramuscular triamcinolone acetonide in pseudogout. J Rheumatol. 1997 Jun;24(6):1168-70.

• 摘要

50.  Doherty M, Dieppe PA. Double blind, placebo controlled trial of magnesium carbonate in chronic pyrophosphate arthropathy. Ann Rheum Dis. 1983;42(suppl 1):106-107.

• 全文

51.  Rothschild B, Yakubov LE. Prospective 6-month, double-blind trial of hydroxychloroquine treatment of CPDD. Compr Ther. 1997 May;23(5):327-31.

• 摘要

52.  Chollet-Janin A, Finckh A, Dudler J, et al. Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis. Arthritis Rheum. 2007 Feb;56(2):688-92.

• 全文
• 摘要

53.  Finckh A, Mc Carthy GM, Madigan A, et al. Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial. Arthritis Res Ther. 2014 Oct 15;16(5):458.

• 全文
• 摘要

54.  Moltó A, Olivé A. Anti-IL-1 molecules: new comers and new indications. Joint Bone Spine. 2010 Mar;77(2):102-7.

• 摘要